AU2001285349A1 - Induction of ldl receptor expression by extracellular-signal regulated kinase, erk-1/2 - Google Patents
Induction of ldl receptor expression by extracellular-signal regulated kinase, erk-1/2Info
- Publication number
- AU2001285349A1 AU2001285349A1 AU2001285349A AU8534901A AU2001285349A1 AU 2001285349 A1 AU2001285349 A1 AU 2001285349A1 AU 2001285349 A AU2001285349 A AU 2001285349A AU 8534901 A AU8534901 A AU 8534901A AU 2001285349 A1 AU2001285349 A1 AU 2001285349A1
- Authority
- AU
- Australia
- Prior art keywords
- erk
- extracellular
- induction
- receptor expression
- ldl receptor
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/10—Transferases (2.)
- C12N9/12—Transferases (2.) transferring phosphorus containing groups, e.g. kinases (2.7)
- C12N9/1205—Phosphotransferases with an alcohol group as acceptor (2.7.1), e.g. protein kinases
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6809—Methods for determination or identification of nucleic acids involving differential detection
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/92—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving lipids, e.g. cholesterol, lipoproteins, or their receptors
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2500/00—Screening for compounds of potential therapeutic value
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/04—Endocrine or metabolic disorders
- G01N2800/044—Hyperlipemia or hypolipemia, e.g. dyslipidaemia, obesity
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US22927100P | 2000-08-30 | 2000-08-30 | |
US60229271 | 2000-08-30 | ||
PCT/US2001/026982 WO2002018654A1 (en) | 2000-08-30 | 2001-08-29 | Induction of ldl receptor expression by extracellular-signal regulated kinase, erk-1/2 |
Publications (1)
Publication Number | Publication Date |
---|---|
AU2001285349A1 true AU2001285349A1 (en) | 2002-03-13 |
Family
ID=22860499
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU2001285349A Abandoned AU2001285349A1 (en) | 2000-08-30 | 2001-08-29 | Induction of ldl receptor expression by extracellular-signal regulated kinase, erk-1/2 |
Country Status (3)
Country | Link |
---|---|
US (1) | US6756410B2 (en) |
AU (1) | AU2001285349A1 (en) |
WO (1) | WO2002018654A1 (en) |
Families Citing this family (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
PE20070335A1 (en) * | 2005-08-30 | 2007-04-21 | Novartis Ag | SUBSTITUTE BENZIMIDAZOLES AND METHODS FOR THEIR PREPARATION |
ATE459338T1 (en) | 2006-07-21 | 2010-03-15 | Novartis Ag | FORMULATIONS FOR BENZIMIDAZOLYLPYRIDYL ETHER |
WO2010100127A1 (en) | 2009-03-04 | 2010-09-10 | Novartis Ag | Disubstituted imidazole derivatives as modulators of raf kinase |
JO3002B1 (en) | 2009-08-28 | 2016-09-05 | Irm Llc | Compounds and compositions as protein kinase inhibitors |
US8242260B2 (en) | 2009-08-28 | 2012-08-14 | Novartis Ag | Compounds and compositions as protein kinase inhibitors |
CN102770426B (en) | 2010-02-05 | 2016-03-23 | 诺瓦提斯公司 | As compound and the composition of kinases inhibitor |
KR20140117684A (en) | 2010-06-25 | 2014-10-07 | 노파르티스 아게 | Heteroaryl compounds and compositions as protein kinase inhibitors |
KR102006917B1 (en) * | 2016-06-01 | 2019-08-02 | 부산대학교 산학협력단 | Pharmaceutical composition comprising ribosome-binding agent for preventing or treating low density lipoprotein-related disease |
-
2001
- 2001-08-29 AU AU2001285349A patent/AU2001285349A1/en not_active Abandoned
- 2001-08-29 US US09/942,320 patent/US6756410B2/en not_active Expired - Fee Related
- 2001-08-29 WO PCT/US2001/026982 patent/WO2002018654A1/en active Application Filing
Also Published As
Publication number | Publication date |
---|---|
WO2002018654A1 (en) | 2002-03-07 |
US20020082192A1 (en) | 2002-06-27 |
US6756410B2 (en) | 2004-06-29 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU7288100A (en) | Regulation of secondary metabolite production | |
ZA200106683B (en) | Method for the preparation of citalopram. | |
HK1054378A1 (en) | Method for the preparation of citalopram. | |
ZA200309471B (en) | Method for the preparation of escitalopram. | |
MXPA03004030A (en) | Process for the preparation of latent antithrombin iii. | |
AU2002356533A1 (en) | Methods using 1, 2-dithiol-3-thiones and their derivatives and metabolites for inhibiting angiogenesis | |
ZA200403432B (en) | Method for the preparation of escitalopram. | |
IL161026A0 (en) | Process for the preparation of citalopram | |
AU2001285349A1 (en) | Induction of ldl receptor expression by extracellular-signal regulated kinase, erk-1/2 | |
AU2001252191A1 (en) | Uses of bombesin receptor 3 | |
MXPA03001800A (en) | Process for the preparation of substituted phenylacetonitriles. | |
AU2002247063A1 (en) | Antisense modulation of casein kinase 2-beta expression | |
AU2002330042A1 (en) | Process for the preparation of 1,5-diarylpyrazoles | |
AU2001272368A1 (en) | Method for the preparation of citalopram | |
AU2002303529A1 (en) | Antidepressant azaheterocyclylmethyl derivatives of 1,4,5-trioxa-phenanthrene | |
IL162188A0 (en) | Process for the preparation of Ä1,4,5Ü-oxadiazepine derivatives | |
AU2002222695A1 (en) | Novel 4'-demethyl-4'-o-substituted-1-deoxypodophyllotoxin derivative and geometric isomer thereof, process for the preparation thereof and anti-cancer composition comprising the same | |
AU2002317420A1 (en) | Process for the preparation of citalopram hydrobromide | |
EP1295864A4 (en) | Process for preparation of 1,5-diaminonaphthalenes | |
MXPA03009210A (en) | New process for the preparation of oxabispidines. | |
IL137364A (en) | Process for the preparation of 6,6-dimethylhept-1-en-4-yn-3-ol | |
AU2002338732A1 (en) | Extracellular regulated kinase 2 (erk2) | |
AU2000258438A1 (en) | An improved process for the preparation of acylferrocenes | |
AU2000279379A1 (en) | An improved process for the preparation of 10h-phenoxazine | |
HK1041606B (en) | Process for the preparation of n,n'-carbonylbislactams |